CN Patent

CN120787232A — Nk-3受体拮抗剂化合物、药物组合物、其制备方法和应用

Assigned to Shandong Luye Pharmaceutical Co Ltd · Expires 2025-10-14 · 1y expired

What this patent protects

本发明涉及一类NK‑3受体拮抗剂化合物，或其药学可接受的盐，或其立体异构体，和含有其的药物组合物。所述化合物，或其药学可接受的盐，或其立体异构体，和药物组合物具有对NK‑3受体的拮抗活性，并可以作为NK‑3受体拮抗剂用于预防或治疗与NK‑3受体的活性或表达量相关的疾病。

USPTO Abstract

本发明涉及一类NK‑3受体拮抗剂化合物，或其药学可接受的盐，或其立体异构体，和含有其的药物组合物。所述化合物，或其药学可接受的盐，或其立体异构体，和药物组合物具有对NK‑3受体的拮抗活性，并可以作为NK‑3受体拮抗剂用于预防或治疗与NK‑3受体的活性或表达量相关的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN120787232A
Jurisdiction
CN
Classification
—
Expires
2025-10-14
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Luye Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.